04/06/2025 00:26
|
Medical, Health & Aged Care
- Approval Based on Positive Results from the Phase 3 HD21 Trial for StageIIb with Risk Factors/III/IV Hodgkin Lymphoma
- ADCETRIS-based Combination Demonstrated Superior Safety Profile and...